Skip to content

Gingivitis Treated With Chlorhexidine 0.12% Mouthwash in Young Adults

Gingivitis Treated With Chlorhexidine 0.12% Mouthwash in Young Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04658225
Enrollment
30
Registered
2020-12-08
Start date
2018-08-01
Completion date
2020-12-01
Last updated
2020-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Problem

Keywords

Gingivitis, Periodontal treatment

Brief summary

The aim of this study will evaluate the effectiveness of 0.12% chlorhexidine solution as an anti-inflammatory agent and reducing the presence of biofilm in young adults.

Detailed description

Thirty patients with gingivitis ages 18 to 30 year with a probing depth of at most 3 mm and at least 20 teeth will be selected and evaluate at baseline and after 4 weeks.

Interventions

the patients were randomly allocated into two groups of 15 individuals to rinse with antimicrobials twice a day for a period of four weeks. Group A, received 0.12% chlorhexidine antimicrobian in a vial previously identified as solution 1 and group B, received saline solution identified as solution 2.

Sponsors

Universidade Federal Fluminense
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

Participant will receiver mouthwash solution with labeled number, they will not know which solution will inside. Care provider - The research that will collect clinical parameter wil be different for researcher that will do the treatment. Investigator will not have contact with treatment.

Intervention model description

Thirty patients with gingivitis ages18 to 30 year with a probing depth of at most 3 mm and at least 20 teeth will select and evaluate at baseline and after 4 weeks. The periodontal clinical parameters will verify: plaque index (PI), gingival index (GI) and Simplified Oral Hygiene Index (OHIS). After evaluation of the clinical parameters, the patients will randomly allocated into two groups of 15 individuals to rinse with antimicrobials twice a day for a period of four weeks. Group A, received 0.12% chlorhexidine antimicrobian in a vial previously identified as solution 1 and group B, received saline solution identified as solution 2.

Eligibility

Sex/Gender
ALL
Age
30 Days to 30 Days
Healthy volunteers
No

Inclusion criteria

* Presence of gingivitis * Probing depth (PD) with maximum 3 mm * Minimum of 20 teeth * Age between 18 and 30 years old

Exclusion criteria

* Patients with periodontal disease (PD ≥ 4mm with clinical attachment loss) * Diabetes * Osteoporosis * Pregnant or lactating females * Smokers * Users of immune suppressive medication * Phenytoin or cyclosporine * Calcium channel blockers * Antibiotics * Nonsteroidal anti-inflammatory drugs * HIV+ or AIDS

Design outcomes

Primary

MeasureTime frameDescription
Plaque Index30 daysCheck the biofilm as Ainano & Bay 1975 index, Higher levels means worse.

Secondary

MeasureTime frameDescription
Gingival Index30 daysCheck the biofilm as Ainano & Bay 1975 index, Higher levels means worse.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026